Clinical Trial Update: EMD 128130 for the Treatment of Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of EMD 128130 for Parkinson's disease has completed. The document does not report the trial outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• EMD 128130

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED